Low-dose aspirin and clopidogrel: How to act in patients scheduled for day surgery

Current Opinion in Anaesthesiology

Volumn 20, Issue 6, 2007, Pages 531-534

  Servin, Frédérique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Ambulatory; Antiplatelet drugs; Aspirin; Clopidogrel; Outpatient

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FLURBIPROFEN; LOW MOLECULAR WEIGHT HEPARIN; PROSTAGLANDIN SYNTHASE; TICLOPIDINE; WARFARIN;

ACETYLATION; ATHEROSCLEROSIS; BLADDER TUMOR; BLEEDING; CARDIOVASCULAR RISK; CORONARY STENT; DRUG EFFECT; DRUG HALF LIFE; DRUG INHIBITION; DRUG RESPONSE; HEART FAILURE; HEART INFARCTION; HUMAN; LOW DRUG DOSE; ORTHOPEDIC SURGERY; OUTPATIENT; PRIORITY JOURNAL; PROSTATE TUMOR; REVIEW; SURGICAL RISK; THROMBOCYTE ACTIVATION; TRANSURETHRAL RESECTION; UNSTABLE ANGINA PECTORIS;

ANESTHESIA; ASPIRIN; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; TICLOPIDINE;

EID: 35948976573     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3282f15f95     Document Type: Review

References (10)

1. Chaer RA, Graham JA, Mureebe L. Platelet function and pharmacologic inhibition. Vasc Endovasc Surg 2006; 40:261-267. Easy to read review of platelet function and of the main pharmacologic features of APD.
2. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99:316-328. A detailed and up-to-date review on the problem of coronary arterial disease patients on dual therapy proposed for noncardiac surgery.
3. Burger W, Chamnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and meta-analysis. J Intern Med 2005; 257:399-414.
4. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc 2007; 138:652-655. Several American scientific societies have joined their efforts to highlight the risk of premature discontinuation of dual antiplatelet therapy in patients with drug-eluting stents. The increased risk lasts longer than previously thought.
5. Dixon AJ, Dixon MP, Dixon JB. Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy. Br J Surg 2007; 24 July [Epub ahead of print]. One of the rare risk stratification studies in a simple clinical setting frequently seen in outpatients.
6. Hussain N, Alsulaiman R, Burtin P, et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther 2007; 25:579-584.
7. Ehrlich Y, Yossepowitch O, Margel D, et al. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial. J Urol 2007; 178:524-528.
8. Hanson RA, Zornow MH, Conlin MJ, Brambrink AM. Laser resection of the prostate: implications for anesthesia. Anesth Analg 2007; 105:475-479. New technologies may help to cope with patients taking APDs. Benign hypertrophy of the prostate may shortly be treated on an ambulatory basis even in patients taking APDs.
9. Masood J, Hafeez A, Calleary J, Barua J. Aspirin use and transrectal ultrasonography-guided prostate biopsy: a national survey. BJU Int 2007; 99: 965-966.
10. Llau JV, De Andres J, Gomar C, et al. Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations. Eur J Anaesthesiol 2007; 24:387-398. The variability of guidelines in different countries stresses the difficulty of defining a scientifically sound attitude towards regional anaesthesia in patients taking APDs.